title: [Thromboembolic risk in inflammatory bowel disease].
abstract: Patients with inflammatory bowel disease have a roughly doubled risk of venous thromboembolic events (and of venous thromboembolic relapse), especially during flare-ups. Antithrombotic prophylaxis should be considered during flare-ups (even when rectal bleeding is present) and should probably been continued after hospital discharge. The treatment of established venous thrombosis and pulmonary embolism should follows the general rules.
authors.forename: Alexandre
authors.initials: A
authors.lastname: Pariente
mesh_terms: D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000503:physiopathology*; D012306:Risk; D013923:Thromboembolism / Q000503:physiopathology* / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents